UBS Adjusts Aveanna Healthcare Price Target to $1.70 From $1.60, Maintains Sell Rating
Aveanna Healthcare Holdings (AVAH) has an average rating of Hold and price targets ranging from $1.70 to $3, according to analysts polled by Capital IQ. Price: 2.44, Change: -0.06, Percent Change: -2.
Analysts' Opinions Are Mixed on These Healthcare Stocks: Oncolytics Biotech (ONCY), Aveanna Healthcare Holdings (AVAH) and Sanofi (OtherSNYNF)
Analyst Estimates: Here's What Brokers Think Of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) After Its First-Quarter Report
Earnings Call Summary | Aveanna Healthcare(AVAH.US) Q1 2024 Earnings Conference
The following is a summary of the Aveanna Healthcare Holdings Inc. (AVAH) Q1 2024 Earnings Call Transcript:Financial Performance:Aveanna Healthcare reported Q1 2024 revenue of $491 million, a 5.2% inc
Aveanna Healthcare Holdings Inc (AVAH) Q1 2024 Earnings: Revenue Rises, Losses Narrow
Aveanna Healthcare Engages Investors With Online Presentation
Aveanna Healthcare Holdings First Quarter 2024 Earnings: Beats Expectations
Truist Financial Sticks to Their Hold Rating for Aveanna Healthcare Holdings (AVAH)
Aveanna Healthcare: Prior Guidance for FY Was Rev of Between $1.96B and $1.98B >AVAH
Aveanna Healthcare: Prior Guidance for FY Was Rev of Between $1.96B and $1.98B >AVAH
Aveanna Healthcare Revises FY24 Revenue Forecast To Greater Than $1.97B (Est $1.975B), Updated From Prior Guidance Of $1.96M-$1.98B
djusted EBITDA of greater than $150 million, updated from prior guidance of Adjusted EBITDA between $146 million and $150 million
Aveanna Healthcare 1Q Rev $490.7M >AVAH
Aveanna Healthcare 1Q Rev $490.7M >AVAH
Aveanna Healthcare 1Q Loss/Shr 6c >AVAH
Aveanna Healthcare 1Q Loss/Shr 6c >AVAH
Aveanna Healthcare's Informative Financial Performance Snapshot
Aveanna Healthcare | 10-Q: Quarterly report
Aveanna Healthcare Hldgs Q1 2024 Adj EPS $(0.03) Beats $(0.05) Estimate, Sales $490.653M Beat $483.976M Estimate
Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. This is a 40 percent increase over losses of $
Aveanna to Participate at the Barclays Leveraged Finance Conference
ATLANTA, May 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the Barclays Leveraged Finance Conference in Austin, TX on May
Aveanna to Participate at the RBC Capital Markets Global Healthcare Conference
ATLANTA, May 01, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the RBC Capital Markets Global Healthcare Conference in New York
Aveanna Announces First Quarter 2024 Earnings Release Date and Conference Call
ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 9,
Loss-Making Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Expected To Breakeven In The Medium-Term
With the business potentially at an important milestone, we thought we'd take a closer look at Aveanna Healthcare Holdings Inc.'s (NASDAQ:AVAH) future prospects. Aveanna Healthcare Holdings Inc., a d
Breakeven On The Horizon For Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)
No Data